Thyrogen 0.9 MG vials
Ended Awarded
- Contract number
- SPE2DR26F4B8L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,409
Award facts
- Contract value 100% obligated
- $26,408.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Thyrogen 0.9 mg vials, a synthetic thyroid-stimulating hormone used in thyroid cancer treatment and diagnostic procedures. This firm fixed-price delivery order, valued at $26,408.50, is scheduled for completion by December 8, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements.
This delivery order operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical products to support military healthcare operations worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent success in supplying specialty pharmaceuticals, brand-name and generic medications, and medical supplies to the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4B8L?
SPE2DR26F4B8L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F4B8L worth?
The government has obligated $26,409 on SPE2DR26F4B8L.
Is contract SPE2DR26F4B8L an order under another contract?
Yes. SPE2DR26F4B8L is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4B8L competed?
The extent of competition for SPE2DR26F4B8L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award